NextCure
Pre-clinicalNextCure will emerge as a global leader in developing novel developing novel therapies to treat cancer through our commitment to scientific innovation, patient needs, and organizational excellence.
Founded
2015
Focus
Biologics
About
NextCure will emerge as a global leader in developing novel developing novel therapies to treat cancer through our commitment to scientific innovation, patient needs, and organizational excellence.
Funding History
3Total raised: $192M
PIPE$50MPfizerDec 15, 2020
IPO$75MUndisclosedMay 9, 2019
Series A$67MLilly VenturesDec 15, 2015
Company Info
TypePrivate
Founded2015
LocationBeltsville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile